Eastman Kodak surged 143 percent yesterday! What will be then?

Here’s a Thought! 30 July, 2020, by Vladimir Rojankovski, Senior Analyst, Grand Capital
Eastman Kodak said yesterday it signed a letter of interest for almost $800 million loan from the U.S. International Development Finance Corporation. The company will use the money to ramp up the development of Kodak Pharmaceuticals, a division tasked with addressing a national shortage of critical pharmaceutical components, including for the ongoing COVID-19 vaccine trials.
Shares of Eastman Kodak surged 143 percent yesterday to trade at $19.29, after touching a new 52-week high of $21.32 earlier. The number of Robinhood investors holding Kodak stock grew nearly eightfold from Tuesday morning to Wednesday afternoon amid the company's extraordinary rally.
“COVID-19 vaccine” is a magic word combination for markets. Almost any company can reasonably expect to capitalize on reporting anything to do with this kind of infection studies or applications. We expect more low-key market participants to use this magic tool for jumping from nowhere into their moments of glory.